Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

418446

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Eyesight: Testing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people were diagnosed with (a) a brain tumour and (b) other conditions as a result of symptoms noticed during examinations by opticians in the last 12 months.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10017
	answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>Information provided by the Health and Social Care Information Centre shows that during 2013/14 there were 159,626 referrals from optometrists to secondary care. It is not possible, however, to identify a diagnosis given the collection of this information is not mandatory.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 17/09/2015 10:07:37 answering member 1201 label Biography information for Alistair Burt
	tabling member	4131 label Biography information for Jim Shannon

418447

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Statins
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to ensure patients prescribed statins can make a choice on what type of statins they receive.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10020
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Decisions regarding the appropriateness of a particular treatment, including statins, should be made by clinicians in partnership with patients. The individual circumstances of each patient should be taken into account, alongside their medical history, needs and preferences.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 10:04:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418448

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what information his Department holds on how many people of what age ranges gave up smoking in each of the last five years.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10021
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The Health and Social Care Information Centre collects this information on behalf of the Department and it is made publicly available at the following web addresses:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx</a></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 10:05:51 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418450

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what criteria NICE has set for new dementia treatments to be recommended for provision by the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10022
	answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>The National Institute for Health and Care Excellence assesses significant new drugs and treatments, including those for the treatment of dementia, through its technology appraisal programme. Technology appraisals are conducted in accordance with NICE’s <em>Guide to the methods of technology appraisal 2013</em> which is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/article/pmg9/chapter/Foreword" target="_blank">www.nice.org.uk/article/pmg9/chapter/Foreword</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/09/2015 15:15:57 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

418449

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alzheimer's Disease: Dental Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will commission a study to investigate potential links between dental treatment and Alzheimer's disease.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10023
	answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>The Department has no plans to commission a study on the specific risk of transmission of Alzheimer’s disease in dentistry. There is no evidence that Alzheimer's disease can be transmitted through any medical procedure. In dentistry, patients are protected from the risk of infection by either mandatory single use instruments, or where instruments are reused, by guidance on strict decontamination procedures as per the Health Technical Memorandum 01-05: Decontamination in primary care dental practices - 2013 edition.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 17/09/2015 16:09:59 answering member 1201 label Biography information for Alistair Burt
	tabling member	4131 label Biography information for Jim Shannon

418936

	registered interest
	date	15/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia: Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions he has had with the Royal College of Physicians on a link between type 2 diabetes and dementia; and what steps he is taking to treat dementia caused in that way.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10243
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS England is implementing the NHS Diabetes Prevention Programme, and it is possible that prevention of Type 2 diabetes may in the longer term reduce dementia risk, although at this point this is speculative rather than being based on evidence.</p><p> </p><p> </p><p> </p><p>The treatment of dementia associated with Type 2 diabetes is as for any dementia, although it is important to also address the Type 2 diabetes and vascular risk. People with dementia who also have diabetes need support to manage their condition.</p><p> </p><p> </p><p> </p><p>Improving the treatment and care of people with dementia, reducing the incidence of dementia and improving dementia research, is a key priority for the Government. That is why in February 2015, the Prime Minister launched his Challenge on Dementia 2020 as a successor to the Prime Minister’s Challenge on Dementia 2012-2015.</p><p> </p><p><strong> </strong></p><p> </p><p>My Rt. hon. Friend the Secretary of State has had and continues to have discussions on these matters with a range of organisations including the Royal College of Physicians.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 15:01:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418940

	registered interest
	date	15/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assistance his Department provides to people addicted to legal highs.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10258
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The dependence-forming potential of many new psychoactive substances (NPS) is still largely unknown, and the number of people attending specialist drug treatment services is relatively small. If users need help, it will more likely be because they have acute NPS-related problems (eg, agitation, palpitations, seizures) and they will probably first present at accident and emergency (A&amp;E) departments.</p><p> </p><p> </p><p> </p><p>Local authorities are responsible for assessing drug treatment needs in their local areas and providing services to meet that need. This includes determining the scale of NPS use and harm in their areas and ensuring there are services to tackle that harm.</p><p> </p><p> </p><p> </p><p>Public Health England (PHE) supports local authorities in their work of assessing need and planning services, by improving data, intelligence and information sharing systems, to ensure prevention and treatment are as effective as they can be in the changing NPS market.</p><p> </p><p> </p><p> </p><p>PHE has produced an NPS toolkit for substance misuse commissioners which gives a broad overview of the challenges from NPS and provides commissioners with resources and advice to inform their work.</p><p> </p><p> </p><p> </p><p>PHE has also supported Project NEPTUNE, which is producing detailed and practical clinical guidance and tools for A&amp;E, drug treatment and other services that deal with people who have NPS problems.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:54:24 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418933

	registered interest
	date	15/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Internet
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to (a) reduce and (b) monitor the sale of prescription drugs on the internet.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10263
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>In the United Kingdom, all categories of medicines may be traded online legally but in the case of prescription only medicines (POM) and pharmacy (P) medicines, these may only be sold or supplied to the public through registered pharmacy premises (by or under the supervision of a pharmacist). Additionally, POMs may only be supplied in response to a prescription from an authorised healthcare professional.</p><p> </p><p> </p><p> </p><p>A UK registered pharmacy may have a presence on the internet; however the requirements of legislation apply equally to both UK internet pharmacies and bricks-and-mortar premises.</p><p> </p><p> </p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) monitors the internet for websites operating outside legal requirements and, in collaboration with Internet Service Providers, takes steps to close down sites both in the UK and abroad. The MHRA has closed down 1,973 websites (including those based overseas) during 2015 alone and brought into compliance many others.</p><p> </p><p> </p><p> </p><p>The illegal sale and supply of medicines via Internet poses considerable risks to UK patients but this is in essence a global problem and the MHRA is working with other regulators, law enforcement authorities and Government Departments within the UK, European Union and elsewhere to address the complex issues involved.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:47:22 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

418935

	registered interest
	date	15/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had with the Royal Colleges on the development and use of progesterone and tamoxifen to treat breast cancer.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10266
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>There have been no such discussions.</p><p> </p><p> </p><p> </p><p>Research into the use of progesterone in combination with tamoxifen for the treatment of breast cancer is still at an early stage and has not yet been trialled in humans.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 21/09/2015 14:41:04 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

418946

	registered interest
	date	15/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cardiovascular System: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to provide renal denervation for the treatment of high blood pressure on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10267
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS England’s Clinical Commissioning Policy Statement <em>Renal Denervation for Resistant Hypertension</em>, published in April 2013, states that NHS England does not routinely commission renal denervation as a treatment for resistant hypertension.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:59:39 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon